Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongming Huang

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Annals of Hematology|July 29, 2024
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort studyJingjing Deng, Xiaoqi Qin, Guangyu Ma, et al.
Haematologica|July 9, 2026
Dual resistance to asparaginase and PD-1 blockade in extranodal natural killer/T-cell lymphoma: dismal outcomes from a multicenter cohortRan Li, Lixia Sheng, Jie Ma, et al.
Nature Communications|April 20, 2024
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trialMing Shi, Jiaojiao Wang, Hongming Huang, et al.
American Journal of Hematology|August 28, 2024
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapyYuekun Qi, Hujun Li, Kunming Qi, et al.
Clinical and Experimental Medicine|November 1, 2023
Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapyHai Cheng, Shengwei Ji, Jiaojiao Wang, et al.
Journal of Virology|September 22, 2021
Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse ModelShi Zou, Yanqin Du, Shunmei Huang, et al.
Frontiers in Immunology|March 12, 2021
Characteristics and Risk Factors of Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell TreatmentZhiling Yan, Huanxin Zhang, Jiang Cao, et al.
Thrombosis Journal|October 4, 2023
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myelomaXiaozhe Li, Xiuli Sun, Baijun Fang, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Annals of Hematology|July 29, 2024
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort studyJingjing Deng, Xiaoqi Qin, Guangyu Ma, et al.
Haematologica|July 9, 2026
Dual resistance to asparaginase and PD-1 blockade in extranodal natural killer/T-cell lymphoma: dismal outcomes from a multicenter cohortRan Li, Lixia Sheng, Jie Ma, et al.
Nature Communications|April 20, 2024
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trialMing Shi, Jiaojiao Wang, Hongming Huang, et al.
American Journal of Hematology|August 28, 2024
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapyYuekun Qi, Hujun Li, Kunming Qi, et al.
Clinical and Experimental Medicine|November 1, 2023
Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapyHai Cheng, Shengwei Ji, Jiaojiao Wang, et al.
Journal of Virology|September 22, 2021
Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse ModelShi Zou, Yanqin Du, Shunmei Huang, et al.
Frontiers in Immunology|March 12, 2021
Characteristics and Risk Factors of Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell TreatmentZhiling Yan, Huanxin Zhang, Jiang Cao, et al.
Thrombosis Journal|October 4, 2023
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myelomaXiaozhe Li, Xiuli Sun, Baijun Fang, et al.
Pageof 9